XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.3

Note 15 - Share-based Payments (Tables)

9 Months Ended

Sep. 30, 2024

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		Three Months Ended September 30, 2024								Three Months Ended September 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,186,961			$	54.30				1,131,882			$	55.84
Granted			146,408				22.02				29,000				20.22
Exercised			-				-				-				-
Forfeited			(19,402	)			33.78				(10,326	)			34.72
Expired			(123,507	)			54.87				(9,161	)			65.19
Outstanding, end of period			1,190,460				45.71				1,141,395				54.83
Options exercisable, end of period			625,627			$	59.02				733,662			$	61.23

		Nine Months Ended September 30, 2024								Nine Months Ended September 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,132,632			$	54.61				1,036,748			$	59.97
Granted			323,358				21.02				166,055				25.29
Exercised			-				-				-				-
Forfeited			(92,374	)			24.73				(32,500	)			61.62
Expired			(173,156	)			56.33				(28,908	)			63.43
Outstanding, end of period			1,190,460				45.71				1,141,395				54.83
Options exercisable, end of period			625,627			$	59.02				733,662			$	61.23

		Three Months Ended September 30, 2024								Three Months Ended September 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			16,779,846			$	1.30				16,463,965			$	1.27
Granted			341,500				1.78				92,000				1.74
Exercised			-				-				-				-
Forfeited			(864,167	)			1.28				(36,667	)			1.27
Expired			(154,701	)			1.27				(15,937	)			1.27
Outstanding, end of period			16,102,478				1.31				16,503,361				1.27
Options exercisable, end of period			9,602,704			$	1.27				6,748,600			$	1.27

		Nine Months Ended September 30, 2024								Nine Months Ended September 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			16,333,233			$	1.27				15,975,528			$	1.27
Granted			1,261,000				1.75				767,500				1.33
Exercised			-				-				-				-
Forfeited			(1,166,121	)			1.29				(207,413	)			1.27
Expired			(325,634	)			1.27				(32,254	)			1.27
Outstanding, end of period			16,102,478				1.31				16,503,361				1.27
Options exercisable, end of period			9,602,704			$	1.27				6,748,600			$	1.27

		Three Months Ended September 30, 2024								Three Months Ended September 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			6,969,256			$	6.00				7,428,662			$	6.00
Granted			-				-				-				6.00
Exercised			-				-				-				-
Forfeited			(350,269	)			6.00				(62,839	)			6.00
Expired			-				-				(49,662	)			6.00
Outstanding, end of period			6,618,987				6.00				7,316,161				6.00
Options exercisable, end of period			4,200,364			$	6.00				2,656,504			$	6.00

		Nine Months Ended September 30, 2024								Nine Months Ended September 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			7,504,269			$	6.00				-			$	-
Granted			123,000				6.00				7,594,000				6.00
Exercised			-				-				-				-
Forfeited			(798,249	)			6.00				(213,650	)			6.00
Expired			(210,033	)			6.00				(64,189	)			6.00
Outstanding, end of period			6,618,987				6.00				7,316,161				6.00
Options exercisable, end of period			4,200,364			$	6.00				2,656,504			$	6.00

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$16.47 - $19.93			57,500			$	19.63				5.4			$	72				27,500			$	19.78				3.9			$	31
$20.25 - $28.37			407,567				22.84				6.4				49				27,618				26.80				5.7				-
$30.70 - $30.74			20,000				30.71				5.2				-				5,000				30.71				5.2				-
$40.04 - $48.00			183,890				42.29				4.6				-				99,827				42.60				4.7				-
$51.82 - $59.98			55,650				55.73				1.4				-				55,650				56.33				1.4				-
$60.01 - $68.41			252,581				62.08				1.9				-				250,873				62.09				1.9				-
$70.13 - $79.51			196,772				78.42				3.2				-				146,784				78.45				3.2				-
$80.61 - $82.07			16,500				81.27				4.0				-				12,375				81.27				4.0				-
			1,190,460			$	45.71				4.3			$	121				625,627			$	59.02				2.9			$	31

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $1.78			16,102,478			$	1.31				5.1			$	7,533				9,602,704			$	1.27				5.0			$	4,890
			16,102,478			$	1.31				5.1			$	7,533				9,602,704			$	1.27				5.0			$	4,890

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $6.00			6,618,987			$	6.00				5.5			$	-				4,200,364			$	6.00				5.5			$	-
			6,618,987			$	6.00				5.5			$	-				4,200,364			$	6.00				5.5			$	-

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

		Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Company options		$	1,429			$	1,819			$	4,104			$	4,999
Wavelo options			422				505				1,380				1,561
Ting options			32				50				144				296
Capitalized stock based compensation			(75	)			(66	)			(245	)			(250	)
Total stock based compensation expense		$	1,808			$	2,308			$	5,383			$	6,606

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration